Roundup and analysis of the top headlines on health security, pandemic preparedness, COVID-19, and other news from the Johns Hopkins Center for Health Security


Please note that some links may require subscription or registration.

May 30, 2024



TOP NEWS

Officials announce third human case related to avian flu outbreak in dairy cows; US government close to finalizing deal to fund late-stage trial of mRNA vaccine


A third human case related to the ongoing H5N1 avian influenza outbreak among dairy cows has been detected in a Michigan dairy farm worker, state health authorities confirmed today. The individual—who, notably, had respiratory and eye symptoms—was in close contact with infected cows. The person worked on a different farm from the one where another previously infected worker was identified. The presence of respiratory symptoms increases the possibility of onward transmission, although there are still no signs of human-to-human transmission related to these cases.


Last week, the US CDC said it is preparing for the “possibility of increased risk to human health” from highly pathogenic avian influenza A(H5N1). Since first being detected in dairy cows in March, the virus has infected at least 67 herds in 9 US states (Texas, New Mexico, Kansas, Colorado, Idaho, South Dakota, Michigan, Ohio, North Carolina) and 3 dairy farm workers exposed to sick cows in 2 states (Texas, Michigan).


Genetic analysis of the HPAI A(H5N1) virus isolated from the first human case in Michigan shows one notable change that is known to be associated with viral adaptation to mammalian hosts. That change—which results in enhanced viral replication and disease severity in research involving mice—has been detected in 99% of dairy cow sequences. The remainder of the genome was also very closely related to cow sequences, suggesting cow-to-human transmission. So far, genomic analysis of both human cases supports CDC’s assessment that the human health risk remains low.


Experts believe the case count of infected humans is almost certainly higher and expect more cases to be identified as surveillance expands (as happened today). Dairy and other farm workers are at the highest risk of infection; however, many are not getting or do not have access to testing, and many farms are not facilitating precautions such as using personal protective equipment (PPE). A preprint study published last week found H5N1 can persist and remain infectious for long periods of time in unpasteurized milk on milking equipment.


Gaining cooperation and trust from frontline farm workers—and facilitating access to testing—is vital to better understanding of how and when spillover infections occur. Last week, the US Department of Agriculture (USDA) expanded financial support for dairy farms to develop and implement biosecurity plans, including screening milk supplies; pay for veterinary costs related to animal testing; compensate eligible farms for lost milk production; and pay farm workers who agree to give blood and nasal swab samples to CDC. Experts say incentives like these can help, but a core piece of the response should include finding, equipping, partnering with, and supporting people who can act as trusted messengers within these communities.


The best defense against avian influenzas is the development of effective vaccines, according to a new review. The US government is nearing a deal to fund a late-stage clinical trial of Moderna’s mRNA avian flu vaccine (mRNA-1018). An announcement on the funding, which would come from the Biomedical Advanced Research and Development Authority (BARDA), could be announced as soon as June and likely would include a promise to purchase doses. The US government is working to fill and finish about 4.8 million doses of CSL Seqirus’s avian flu vaccine and is also in ongoing discussions with Pfizer. European officials are in talks to acquire CSL’s vaccine. Results from a promising preclinical study of an investigational mRNA vaccine targeting the H5N1 clade widely circulating were published last week.


Other recent developments related to H5N1 include:



World Health Assembly working to decide timeline, process for ongoing pandemic agreement negotiations after failing to reach deadline, to reach consensus on IHR amendments


After more than 2 years of negotiations, WHO member states failed to reach consensus on several critical issues in the draft pandemic agreement before the 77th World Health Assembly (WHA), which began on May 27. While most of the draft text is agreed upon, divergent views remain, particularly on the proposed pathogen access and benefits sharing (PABS) mechanism, which aims to ensure that the sharing of pathogen data would enable equitable access to any resulting medical countermeasures. Another area of contention is financing, including whether to establish a dedicated fund or use existing resources such as the Pandemic Fund.


But hope is not lost. WHO Director-General Dr. Tedros Adhanom Ghebreyesus, Africa Centres for Disease Control and Prevention Director-General Dr. Jean Kaseya, and US officials, including Secretary of Health and Human Services Xavier Becerra, all expressed optimism that member states will eventually reach an agreement.


The timeframe for doing so, however, is undetermined. The Africa region expressed its desire to reach consensus by the end of this year at a special meeting of the WHA, while the US and others pushed for an extension of negotiations for at least 1 year to address “complex technical issues.” Notably, if former President Donald Trump wins the US presidential election in November, his administration very likely will not support any ongoing negotiations and would again withdrawal from WHO.


The draft agreement negotiations have been plagued by vast amounts of misinformation and disinformation, including false claims that the treaty would give WHO authority to impose lockdowns or force vaccinations. In many countries, including the US and UK, discussion surrounding the treaty have become politicized over unfounded concerns about threats to national sovereignty; however, the draft text reaffirms states’ sovereignty “in addressing public health matters” and “over their biological resources.”


Parallel negotiations to update the International Health Regulations (IHR) appear to be moving forward. Several western nations, including France, Norway, Ireland, and the US, called for a deal on IHR amendments to be reached this week. The IHR updates include proposed additions and revisions to issues pertaining to defining and communicating health emergencies, obligations regarding “health products,” financing, and implementation and compliance. Because the IHR updates include mention of a pandemic agreement, and vice versa, some nations, including Uganda and Tanzania, are pushing for both the IHR updates and pandemic agreement to be handled together.


A new WHA drafting committee met this week to determine a process for adopting both measures and could report back to the WHA as soon as today. 

MORE HEADLINES

Opinion pieces, analyses examine pandemic treaty negotiations, importance of reaching agreement

STAT: The world needs the new pandemic treaty

Project Syndicate: How to Protect the World from the Next Pandemic

Think Global Health: Why Pandemic Agreement Negotiations Failed to Land

The Telegraph: The West should be on a war footing for the next pandemic

New York Times: The Stalled Pandemic Accords Offer an Opportunity for Vaccine Equity

Think Global Health: Safeguarding the Pandemic Agreement from Disinformation

Devex: Opinion: Protecting pandemic preparedness efforts in a US election year

The Hill: Even in this crucial election year, we can’t ignore pandemic preparedness


Experts call for greater focus on therapeutic development in future pandemic response efforts

Devex: Experts call for greater emphasis of therapeutics in pandemic response

Health Policy Watch: Next Pandemic Needs to ‘Focus More on Therapeutics’


Africa CDC, CEPI, Gavi work to strengthen regional vaccine research, development, manufacturing to bolster pandemic preparedness

Africa CDC: Africa CDC and CEPI deepen partnership to fortify African preparedness against disease outbreaks

Devex: Gavi, the Vaccine Alliance, has no 'magic wand,' says new CEO


Newly released documents reveal exploitative, secretive nature of COVID-19 vaccine makers’ negotiations in South Africa, show need for equity in pandemics

The BMJ: Covid-19: South African disclosures reveal secretive world of nations’ vaccine contracts

Devex: How Big Pharma kept COVID-19 vaccine negotiations in South Africa secret

Health Policy Watch: Moderna’s Outsized Price Ask for COVID Vaccines in South Africa Highlights Need to ‘Rein in Corporates’ in Pandemics

See also: New York Times: Inside the Factory Supplying Half of Africa’s Syringes


UK pauses work on planned health security research facility; House of Commons proposes review of costs, delayed timeline

BBC: Work paused on dangerous pathogens research facility

The Standard: Pathogens research centre delayed for 15 years as costs rise by 500%, warn MPs

See also: Bulletin of the Atomic Scientists: To protect global health security, Africa needs more pathogen research labs (opinion)


US likely to see increase in COVID-19 cases this summer, driven by KP subvariants known as ‘FLiRT’

Washington Post: Covid will still be here this summer. Will anyone care?

Los Angeles Times: Signs of rising COVID in California as new FLiRT subvariants dominate

Hawaii News Now: Health Department monitoring rise in COVID cases

Reuters: The FLiRT COVID variants: What are they and are they more contagious?

See also: MedPage Today: COVID Shots Could Use Another Update, Study Suggests


COVID-19 pandemic erased decade of gains in life expectancy between 2019-2021, WHO says

UN News: COVID-19 eliminated a decade of progress in global level of life expectancy

Health Policy Watch: WHO Report: COVID Eliminated a decade of progress in life expectancy


Hospitalized COVID patients at increased risk of death, health impacts 3 years after acute infection compared with nonhospitalized individuals, study shows

Ground Truths: Long Covid at 3 Years

Fortune: COVID can cause new health problems to appear years after infection, according to a study of more than 130,000 patients

Nature Medicine: Three-year outcomes of post-acute sequelae of COVID-19


Many patients of color experiencing long COVID symptoms struggle to get care; advocates call for more federal research funding

Washington Post: In communities of color, long-covid patients are tired of being sick and neglected

Washington Post: Patients of color struggle to get attention for long covid

The Hill: Long COVID research advocates hammer Biden over ‘minimal funding’ in budget request

See also: Politico: Moderna’s long Covid plan


Various studies examine prevention of, risk for long COVID, other post-COVID conditions

The Hill: Vaccines lower risk of long COVID: Study

CIDRAP: Pregnant women with COVID-19 may be at lower risk for long COVID

CIDRAP: COVID patients at higher risk for respiratory complications well after infection, study finds

Nature Medicine: Generating clinical evidence for treatment and prevention options for long COVID


US House lawmakers accuse NIH senior advisor of evading Freedom of Information Act by using personal email accounts, deleting correspondence

New York Times: Health Officials Tried to Evade Public Records Laws, Lawmakers Say

Science: House panel takes Fauci adviser to task for allegedly evading public records laws

The Nation: At the NIH, a Scandal Grows Around an Official’s Evasion of Public Records Law

Wall Street Journal: What Was Anthony Fauci’s Top Aide Hiding? (opinion)

New York Times: A Blistering Congressional Hearing Forces Accountability on Covid Origins (opinion)


China reports fatal H5N6 avian flu case, marking country’s 90th case since 2014

CIDRAP: China reports fatal H5N6 avian flu case

Reuters: Bird flu found in western China as US combats cattle outbreak


2 doses of Jynneos mpox vaccine offers near complete protection from infection; US averaging 59 cases per week, mainly among unvaccinated

NBC News: CDC says vaccination could protect the U.S. from more dangerous mpox virus

MedPage Today: CDC: Less Than 1% of Mpox Cases Occurred After Two Doses of Jynneos Vaccine

CIDRAP: Report: Mpox infections after 2 doses of Jynneos rare

See also: WHO: Strategic Framework for Enhancing Prevention and Control of mpox- 2024-2027.


Several new developments give hope to efforts to stem malaria

The Economist: New fronts are opening in the war against malaria

MIT News: Scientists identify mechanism behind drug resistance in malaria parasite

BBC: GMO mosquitoes released in Djibouti to fight malaria

Grist: Pregnant in a warming climate: A lethal ‘double risk’ for malaria


Central African Republic first country to receive new malaria vaccine; makers call for additional orders to lower costs, meet demand

NPR: New malaria vaccine delivered for the first time

Financial Times: Malaria vaccine makers call for more orders to drive down costs


PAHO urges countries take stronger steps to prevent dengue infections; warming weather expanding Aedes aegypti mosquito range into US

NBC News: Dengue fever, once confined to the tropics, now threatens the U.S.

CIDRAP: PAHO issues dengue alert for Central America, Mexico, Caribbean

See also: Nature Communications: Human movement and environmental barriers shape the emergence of dengue


WHO to have growing focus on climate change; need to fill gaps in understanding of impacts on tropical diseases, study says

Health Policy Watch: Climate Change to Be Major Focus for WHO in Coming Years

UN News: ‘Critical gaps’ in understanding climate change fuel tropical disease spread

See also: AP: Extreme weather. A lack of lifesaving vaccines. Africa’s cholera crisis is worse than ever


Brazil area hit by devastating floods now facing outbreak of leptospirosis; many of those displaced by flooding say they will not return home

The Telegraph: ‘Seek care immediately’: Four dead in outbreak of waterborne disease following Brazil floods

Washington Post: The climate refugee crisis is here

See also: ABC News: Papua New Guinea landslide raises risk of disease outbreaks, mental health impacts


New reports outline recommendations for accelerated, sustainable response to antimicrobial resistance; World Health Assembly strategic roundtable to address issue

The Lancet: The Lancet Series on Antimicrobial Resistance: The need for sustainable access to effective antibiotics

UN Environment Programme: Quadripartite Key Recommendations and Priorities for the 2024 UNGA High-Level Meeting on Antimicrobial Resistance (AMR) - A Policy Brief

WHO: Charting a new path forward for global action against antimicrobial resistance

See also: NPR: How the pandemic gave power to superbugs


US CDC warns of multi-state salmonella outbreak associated with backyard chickens, launches investigation

USA Today: Salmonella outbreak linked to backyard chickens, ducks prompts CDC investigation

Medical Xpress: CDC warns again of salmonella tied to backyard poultry

Reuters: US CDC warns of multi-state salmonella outbreak linked to backyard poultry

FROM THE CENTER

New webpage outlines Center for Health Security’s work on intersection of AI, biotechnology

 

The convergence of artificial intelligence and biotechnology (AIxBio) has the potential to yield extraordinary benefits as well as serious risks. A new webpage presents the Johns Hopkins Center for Health Security’s work on AIxBio, including reports, policy documents, event summaries, and news.


AI technologies could revolutionize how healthcare is organized and delivered, how medicines and vaccines are developed, how diseases are diagnosed, and the speed with which new outbreaks are detected. However, new AI models could also increase the risk of high-consequence accidents or misuse of biology and the life sciences. Therefore, balancing the potential benefits of AI in public health, biosecurity, and healthcare and the narrow subset of high-consequence dual-use risks is crucial.


By conducting research and providing evidence-based recommendations, the Center for Health Security hopes to assist policymakers and other stakeholders address these challenges proactively, enabling the world to harness the full potential of AI in biotechnology while safeguarding against potential threats to health security. Visit the new page here: https://centerforhealthsecurity.org/our-work/aixbio. 

Editor: Alyson Browett, MPH

Contributing Editor: Prarthana Vasudevan, MS, MSPH, DrPH (c)

Give Today
Click to Subscribe
 
Twitter  Youtube  Linkedin